• Something wrong with this record ?

Cytotoxic activity of sanguinarine and dihydrosanguinarine in human promyelocytic leukemia HL-60 cells

J. Vrba, P. Doležel, J. Vičar, J. Ulrichová

. 2009 ; 23 (4) : 580-588.

Language English Country Great Britain

Document type Research Support, Non-U.S. Gov't

The benzo[c]phenanthridine alkaloid sanguinarine has been studied for its antiproliferative activity in many cell types. Almost nothing however, is known about the cytotoxic effects of dihydrosanguinarine, a metabolite of sanguinarine. We compared the cytotoxicity of sanguinarine and dihydrosanguinarine in human leukemia HL-60 cells. Sanguinarine produced a dose-dependent decline in cell viability with IC(50) (inhibitor concentration required for 50% inhibition of cell viability) of 0.9 microM as determined by MTT assay after 4h exposure. Dihydrosanguinarine showed much less cytotoxicity than sanguinarine: at the highest concentration tested (20 microM) and 24h exposure, dihydrosanguinarine decreased viability only to 52%. Cytotoxic effects of both alkaloids were accompanied by activation of the intrinsic apoptotic pathway since we observed the dissipation of mitochondrial membrane potential, induction of caspase-9 and -3 activities, the appearance of sub-G(1) DNA and loss of plasma membrane asymmetry. This aside, sanguinarine also increased the activity of caspase-8. As shown by flow cytometry using annexin V/propidium iodide staining, 0.5 microM sanguinarine induced apoptosis while 1-4 microM sanguinarine caused necrotic cell death. In contrast, dihydrosanguinarine at concentrations from 5 microM induced primarily necrosis, whereas apoptosis occurred at 10 microM and above. We conclude that both alkaloids may cause, depending on the alkaloid concentration, both necrosis and apoptosis of HL-60 cells.

000      
02958naa 2200349 a 4500
001      
bmc11017128
003      
CZ-PrNML
005      
20120322151427.0
008      
110629s2009 xxk e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Vrba, Jiří, $d 1971- $7 xx0042118
245    10
$a Cytotoxic activity of sanguinarine and dihydrosanguinarine in human promyelocytic leukemia HL-60 cells / $c J. Vrba, P. Doležel, J. Vičar, J. Ulrichová
314    __
$a Department of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacky University, Hnevotinska 3, 775 15 Olomouc, Czech Republic. vrbambv@seznam.cz
520    9_
$a The benzo[c]phenanthridine alkaloid sanguinarine has been studied for its antiproliferative activity in many cell types. Almost nothing however, is known about the cytotoxic effects of dihydrosanguinarine, a metabolite of sanguinarine. We compared the cytotoxicity of sanguinarine and dihydrosanguinarine in human leukemia HL-60 cells. Sanguinarine produced a dose-dependent decline in cell viability with IC(50) (inhibitor concentration required for 50% inhibition of cell viability) of 0.9 microM as determined by MTT assay after 4h exposure. Dihydrosanguinarine showed much less cytotoxicity than sanguinarine: at the highest concentration tested (20 microM) and 24h exposure, dihydrosanguinarine decreased viability only to 52%. Cytotoxic effects of both alkaloids were accompanied by activation of the intrinsic apoptotic pathway since we observed the dissipation of mitochondrial membrane potential, induction of caspase-9 and -3 activities, the appearance of sub-G(1) DNA and loss of plasma membrane asymmetry. This aside, sanguinarine also increased the activity of caspase-8. As shown by flow cytometry using annexin V/propidium iodide staining, 0.5 microM sanguinarine induced apoptosis while 1-4 microM sanguinarine caused necrotic cell death. In contrast, dihydrosanguinarine at concentrations from 5 microM induced primarily necrosis, whereas apoptosis occurred at 10 microM and above. We conclude that both alkaloids may cause, depending on the alkaloid concentration, both necrosis and apoptosis of HL-60 cells.
590    __
$a bohemika - dle Pubmed
650    _2
$a apoptóza $x účinky léků $7 D017209
650    _2
$a benzofenantridiny $x farmakologie $7 D053119
650    _2
$a kaspasy $x metabolismus $7 D020169
650    _2
$a buněčný cyklus $x účinky léků $7 D002453
650    _2
$a viabilita buněk $x účinky léků $7 D002470
650    _2
$a HL-60 buňky $7 D018922
650    _2
$a lidé $7 D006801
650    _2
$a isochinoliny $x farmakologie $7 D007546
650    _2
$a membránový potenciál mitochondrií $x účinky léků $7 D053078
655    _2
$a práce podpořená grantem $7 D013485
700    1#
$a Doležel, Petr. $7 xx0317513
700    1_
$a Vičar, Jaroslav, $d 1946-2010 $7 ola2002158252
700    1_
$a Ulrichová, Jitka, $d 1956- $7 ola2002158251
773    0_
$t Toxicology in Vitro $g Roč. 23, č. 4 (2009), s. 580-588 $x 0887-2333 $w MED00004536
910    __
$a ABA008 $b x $y 2
990    __
$a 20110720101713 $b ABA008
991    __
$a 20120322151411 $b ABA008
999    __
$a ok $b bmc $g 864170 $s 726923
BAS    __
$a 3
BMC    __
$a 2009 $b 23 $c 4 $d 580-588 $i 0887-2333 $m Toxicology in vitro $n Toxicol In Vitro $x MED00004536
LZP    __
$a 2011-3B09/BBjvme

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...